Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Memorial Sloan-Kettering Cancer Center |
---|---|
Information provided by: | Memorial Sloan-Kettering Cancer Center |
ClinicalTrials.gov Identifier: | NCT00579800 |
The purpose of this study is to evaluate new computer software on breast magnetic resonance imaging (MRI). The information from this study may help doctors and scientists develop better ways to find breast cancer, and may help future patents with cancer.
Condition | Intervention |
---|---|
Breast Cancer |
Procedure: new software sequences, Vibrant-DE and IDEAL |
Study Type: | Interventional |
Study Design: | Diagnostic, Open Label, Single Group Assignment, Efficacy Study |
Official Title: | Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation |
Estimated Enrollment: | 100 |
Study Start Date: | July 2007 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
women undergoing routine breast MRI: Experimental
Conventional images will be taken using the standard sequences consisting of T2-weighted imaging and T1-weighted imaging before and after contrast; these will be used for the diagnostic examination. Following the diagnostic examination, two additional sequences, Vibrant-DE and IDEAL, will be performed on all 20 patients
|
Procedure: new software sequences, Vibrant-DE and IDEAL
Conventional images will be taken using the standard sequences consisting of T2-weighted imaging and T1-weighted imaging before and after contrast; these will be used for the diagnostic examination. Following the diagnostic examination, two additional sequences, Vibrant-DE and IDEAL, will be performed on all 20 patients
|
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Elizabeth Morris, MD | morrise@mskcc.org |
United States, New York | |
Memorial Sloan-Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Elizabeth Morris, MD morrise@mskcc.org |
Principal Investigator: | Elizabeth Morris, MD | Memorial Sloan-Kettering Cancer Center |
Responsible Party: | Memorial Sloan-Kettering Cancer Center ( Elizabeth Morris, MD ) |
Study ID Numbers: | 07-091 |
Study First Received: | December 20, 2007 |
Last Updated: | December 17, 2008 |
ClinicalTrials.gov Identifier: | NCT00579800 |
Health Authority: | United States: Institutional Review Board |
Vibrant-DE IDEAL MRI Breast |
Skin Diseases Breast Neoplasms Breast Diseases |
Neoplasms Neoplasms by Site |